TerrAscend (OTC: TRSSF)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of TerrAscend (OTCQX: TRSSF) through any online brokerage.
There are no as such competitors for TerrAscend.
The latest price target for TerrAscend (OTCQX: TRSSF) was reported by Craig-Hallum on Friday, August 12, 2022. The analyst firm set a price target for 2.00 expecting TRSSF to rise to within 12 months (a possible 11.73% upside). 9 analyst firms have reported ratings in the last year.
The stock price for TerrAscend (OTCQX: TRSSF) is $1.79 last updated August 24, 2022, 7:59 PM UTC.
There are no upcoming dividends for TerrAscend.
TerrAscend does not have any upcoming earnings scheduled.
There is no upcoming split for TerrAscend.
TerrAscend is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQX.